In our study, we constructed a PMRI based on immunotherapy datasets and from the perspective of the multifaceted regulation of PD-L1 expression in cancer cells and found that it not only correlated significantly with TMB and MSI, but also validated its effectiveness in predicting immunotherapy efficacy in patients with BCa using the TIDE algorithm and external immunotherapy datasets. This evidence concerns the gene CD274 and cancer.